THERAVANCE BIOPHARMA INC's ticker is and the CUSIP is G8807B906. A total of 4 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 338,000 | $3,427,000 | 0.05% |
| SIMPLEX TRADING, LLC | 91,400 | $926,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 20,400 | $207,000 | 0.00% |